| Pharmaceutical active ingredients: |
| Estradiol HemihydrateNorethindrone Acetate |
| Available forms, composition and doses of Evorel Pak: |
| 4 Evorel Patches; Topical; Estradiol Hemihydrate 1.6 mg / 4 Evorel Conti Patches; Topical; Estradiol Hemihydrate 3.2 mg; Norethindrone Acetate 11.2 mg4 Evorel Patches; Topical; Estradiol Hemihydrate 3.2 mg / 4 Evorel Conti Patches; Topical; Estradiol Hemihydrate 3.2 mg; Norethindrone Acetate 11.2 mg4 Evorel Patches; Topical; Estradiol Hemihydrate 6.4 mg / 4 Evorel Conti Patches; Topical; Estradiol Hemihydrate 3.2 mg; Norethindrone Acetate 11.2 mg |
| Evorel Pak medical category: |
| Human:EstrogensProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03CA53 - Estradiol, combinationsG03FA01 - Norethisterone and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Janssen |